{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T15:04:29Z","timestamp":1777215869209,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.humpath.2025.105737","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:54:53Z","timestamp":1740156893000},"page":"105737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Beta-2-microglobulin positive tumor cells and CD8 positive lymphocytes are associated with outcome in post-neoadjuvant colorectal cancer resections"],"prefix":"10.1016","volume":"155","author":[{"given":"Soo Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"Pankaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9822-7112","authenticated-orcid":false,"given":"Osman","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105737_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2025.105737_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23516","article-title":"Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation","volume":"113","author":"Quah","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.105737_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.sla.0000154551.06768.e1","article-title":"Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule","volume":"241","author":"Rullier","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2025.105737_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-5-73","article-title":"Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients","volume":"5","author":"Andreoni","year":"2007","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German cao\/aro\/aio-94 randomized phase iii trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0360-3016(98)00180-1","article-title":"Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up","volume":"42","author":"Wagman","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2025.105737_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (checkmate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to pd-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.humpath.2025.105737_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, nccn clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2025.105737_bib13","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"Pd-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41379-018-0114-7","article-title":"Cellular localization of pd-l1 expression in mismatch-repair-deficient and proficient colorectal carcinomas","volume":"32","author":"Liu","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/his.14719","article-title":"Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon","volume":"81","author":"Yilmaz","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105737_bib16","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2025.105737_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"Tgfbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2025.105737_bib18","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.humpath.2025.105737_bib19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-06-4806","article-title":"The adaptive immunologic microenvironment in colorectal cancer: a novel perspective","volume":"67","author":"Galon","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2025.105737_bib20","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory t cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-specific hla loss and immune escape in lung cancer evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2025.105737_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to pd-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib23","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.1021\/bi980573c","article-title":"Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance","volume":"37","author":"Ogretmen","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.humpath.2025.105737_bib24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2025.105737_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1448332","article-title":"Blockade of lag3 enhances responses of tumor-infiltrating t cells in mismatch repair-proficient liver metastases of colorectal cancer","volume":"7","author":"Zhou","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.humpath.2025.105737_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105737_bib27","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10350-005-0133-6","article-title":"Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer","volume":"48","author":"Gavioli","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.humpath.2025.105737_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00262-019-02306-y","article-title":"Prognostic value of tumour-infiltrating cd8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (Ido1) a friend or foe?","volume":"68","author":"Schollbach","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.humpath.2025.105737_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","article-title":"Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy","volume":"236","author":"Ruo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2025.105737_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0360-3016(98)00345-9","article-title":"Prognostic implications of downstaging following preoperative radiation therapy for operable t3-t4 rectal cancer","volume":"42","author":"Kaminsky-Forrett","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2025.105737_bib31","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/s41379-022-01128-1","article-title":"Programmed death-ligand 1 expression in the immune compartment of colon carcinoma","volume":"35","author":"Yilmaz","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41379-022-01095-7","article-title":"Correlation of clinical, pathologic, and genetic parameters with intratumoral immune milieu in mucinous adenocarcinoma of the colon","volume":"35","author":"Neyaz","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqae066","article-title":"Beta2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma","author":"Lee","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib34","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.humpath.2012.01.020","article-title":"International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems","volume":"43","author":"Chetty","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2003.10.045","article-title":"Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the lyon r0-04 phase ii trial","volume":"21","author":"Gerard","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib36","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"Pd-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105737_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41416-023-02372-1","article-title":"Immune microenvironment and lymph node yield in colorectal cancer","volume":"129","author":"Lee","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2025.105737_bib38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41416-022-01700-1","article-title":"Primary tumour immune response and lymph node yields in colon cancer","volume":"126","author":"Lal","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2025.105737_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1477-7819-11-292","article-title":"The effect of preoperative chemoradiotherapy on lymph nodes harvested in tme for rectal cancer","volume":"11","author":"Scabini","year":"2013","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib40","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2025.105737_bib41","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105737_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2025.105737_bib43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.immuni.2016.02.025","article-title":"Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability","volume":"44","author":"Mlecnik","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.humpath.2025.105737_bib44","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.19.03205","article-title":"Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage iii colon cancer","volume":"38","author":"Mlecnik","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105737_bib45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.trsl.2015.06.019","article-title":"Tumor-infiltrating lymphocytes, forkhead box p3, programmed death ligand-1, and cytotoxic t lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer","volume":"166","author":"Teng","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.humpath.2025.105737_bib46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2025.105737_bib47","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cas.13542","article-title":"Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer","volume":"109","author":"Matsutani","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2025.105737_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00262-007-0396-y","article-title":"Clinical impact of hla class i expression in rectal cancer","volume":"57","author":"Speetjens","year":"2008","journal-title":"Cancer Immunol Immunother"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T01:15:40Z","timestamp":1741050940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"alternative-id":["S0046817725000243"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105737","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-2-microglobulin positive tumor cells and CD8 positive lymphocytes are associated with outcome in post-neoadjuvant colorectal cancer resections","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105737"}}